DOCN (DOCN) holder plans NYSE sale of 4,456 common shares

Rhea-AI Filing Summary

A holder of DOCN common stock plans to sell 4,456 shares through Fidelity Brokerage Services LLC on or after 08/13/2026, with trading on the NYSE. The planned sale has an aggregate market value of $589,840.72. DOCN had 117,579,550 shares outstanding. The shares to be sold were acquired via an Employee Stock Purchase Plan (644 shares on 05/20/2025 for cash) and restricted stock vesting (3,812 shares on 06/01/2025 as compensation).

Key Figures

Shares to be sold: 4,456 shares Aggregate market value: $589,840.72 Shares outstanding: 117,579,550 shares +3 more

6 metrics

Shares to be sold 4,456 shares Planned DOCN common stock sale on or after 08/13/2026

Aggregate market value $589,840.72 Value of 4,456 DOCN common shares to be sold

Shares outstanding 117,579,550 shares DOCN common stock outstanding referenced in notice

ESPP shares acquired 644 shares DOCN shares from ESPP purchase on 05/20/2025

Restricted stock vested 3,812 shares DOCN restricted stock vesting on 06/01/2025 as compensation

Proposed sale date 08/13/2026 Intended date for DOCN share sale on NYSE

Key Terms

Form 144, ESPP Purchase, Restricted Stock Vesting

3 terms

Form 144 regulatory

"144: Securities Information Common | Fidelity Brokerage Services"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

ESPP Purchase financial

"Common | 05/20/2025 | ESPP Purchase | Issuer"

Restricted Stock Vesting financial

"Common | 06/01/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

How many DOCN shares are proposed for sale in this Form 144?

The holder plans to sell 4,456 shares of DOCN common stock. The planned transaction has an aggregate market value of $589,840.72 and is expected to be executed on or after 08/13/2026 on the NYSE.

What is the aggregate market value of DOCN shares to be sold?

The aggregate market value of the DOCN shares proposed for sale is $589,840.72. This value relates to the planned sale of 4,456 common shares to be traded on the NYSE through Fidelity Brokerage Services LLC.

When is the proposed sale date for the DOCN shares in this notice?

The proposed sale date for the DOCN common shares is 08/13/2026. The Form 144 indicates that 4,456 shares may be sold on or after this date on the NYSE through Fidelity Brokerage Services LLC.

How were the DOCN shares being sold originally acquired?

The 4,456 DOCN shares come from two sources: 644 shares were acquired via an ESPP purchase on 05/20/2025 for cash, and 3,812 shares came from restricted stock vesting on 06/01/2025 as compensation.

What is DOCN’s total shares outstanding referenced in this Form 144?

DOCN has 117,579,550 shares of common stock outstanding, as referenced in the notice. This figure provides context and indicates that the 4,456 shares proposed for sale represent only a small portion of total shares.

Which broker is handling the proposed DOCN share sale?

The proposed DOCN share sale will be handled by Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. This broker is listed for the planned sale of 4,456 DOCN common shares on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 10:11 AM Accepted by SEC EDGAR 08/13/2026 - 10:10 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4456	589840.72	117579550	08/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2025	ESPP Purchase	Issuer			644	05/20/2025	Cash
Common	06/01/2025	Restricted Stock Vesting	Issuer			3812	06/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)